Gerresheimer subsidiary Sensile Medical said today it won CE Mark approval in the European Union for its wearable micropump intended for use in the treatment of Parkinson’s disease. The newly cleared device features automatic filling for use with liquid medicines, and includes a color display, charging unit and leather bag which allows the device to be worn […]
Gerresheimer to acquire Sensile Medical and its drug-delivery tech
Gerresheimer plans to acquire Swiss medical technology company Sensile Medical and its array of liquid drug delivery devices. The buyout is a perfect fit in Gerresheimer’s portfolio, the company explained, since it will boost Gerresheimer’s drug delivery offerings and add new digital and electronic capabilities into the mix. Get the full story at our sister site, Drug Delivery […]
Sensile Medical partners with Verily, Sanofi to develop connected insulin patch pump
Swiss medical device-maker Sensile Medical announced this week that it struck a deal with Verily and Sanofi (NYSE:SNY) to develop and commercialize a connected insulin patch pump. The pre-filled insulin patch pump will be designed primarily for people with Type II diabetes, according to the Olten, Switzerland-based company. Get the full story at our sister site, Drug Delivery Business News.
Jawbone agrees to pony up more than $100M for BodyMedia’s wearable sensors | Wall Street Beat
Jawbone agreed to acquire BodyMedia, reportedly for more than $100 million, in a bid to expand its footprint in the wearable technology market.
San Francisco-based Jawbone did not disclose the deal’s value, but Reuters, citing "a person familiar with the matter," reported that it’s worth "north of $100 million."
Pittsburgh-based BodyMedia’s roughly 60 employees will "join Jawbone’s existing team," according to a press release.
